MRNA is S&P 500's top performing stock, here are the best Quant pharma companies
Source: SeekingAlpha
2026-01-21 14:36:34 ET
More on pharmaceuticals
- XPH: Healthcare Dashboard For January
- Why PPH Keeps Working When Single Themes Break
- Healthcare Dashboard For December And Focus On PJP
- Market Voices: Trump on Venezuela, CPI data issues, drug pricing deals
- Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock
Read the full article on Seeking Alpha
For further details see:
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies
Septerna Inc.
NASDAQ: SEPN
SEPN Trading
-3.88% G/L:
$25.92 Last:
109,260 Volume:
$25.86 Open:
SEPN Latest News
March 09, 2026 04:05:00 pm
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
March 01, 2026 09:45:00 am
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
February 10, 2026 04:05:00 pm
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SEPN Stock Data
$1,195,470,926
19,969,290
0.21%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
